These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 18971369

  • 1. Dense deposit disease: clinicopathologic study of 32 pediatric and adult patients.
    Nasr SH, Valeri AM, Appel GB, Sherwinter J, Stokes MB, Said SM, Markowitz GS, D'Agati VD.
    Clin J Am Soc Nephrol; 2009 Jan; 4(1):22-32. PubMed ID: 18971369
    [Abstract] [Full Text] [Related]

  • 2. Prognostic factors and therapy assessment of IgA nephropathy: report from a single unit in iran.
    Soleymanian T, Najafi I, Salimi BH, Broomand B.
    Ren Fail; 2011 Jan; 33(6):572-7. PubMed ID: 21663387
    [Abstract] [Full Text] [Related]

  • 3. C1q nephropathy: a variant of focal segmental glomerulosclerosis.
    Markowitz GS, Schwimmer JA, Stokes MB, Nasr S, Seigle RL, Valeri AM, D'Agati VD.
    Kidney Int; 2003 Oct; 64(4):1232-40. PubMed ID: 12969141
    [Abstract] [Full Text] [Related]

  • 4. Eculizumab in Pediatric Dense Deposit Disease.
    Oosterveld MJ, Garrelfs MR, Hoppe B, Florquin S, Roelofs JJ, van den Heuvel LP, Amann K, Davin JC, Bouts AH, Schriemer PJ, Groothoff JW.
    Clin J Am Soc Nephrol; 2015 Oct 07; 10(10):1773-82. PubMed ID: 26316621
    [Abstract] [Full Text] [Related]

  • 5. C3 glomerulopathy: clinicopathologic features and predictors of outcome.
    Medjeral-Thomas NR, O'Shaughnessy MM, O'Regan JA, Traynor C, Flanagan M, Wong L, Teoh CW, Awan A, Waldron M, Cairns T, O'Kelly P, Dorman AM, Pickering MC, Conlon PJ, Cook HT.
    Clin J Am Soc Nephrol; 2014 Jan 07; 9(1):46-53. PubMed ID: 24178974
    [Abstract] [Full Text] [Related]

  • 6. Heterogeneous histologic and clinical evolution in 3 cases of dense deposit disease with long-term follow-up.
    Figuères ML, Frémeaux-Bacchi V, Rabant M, Galmiche L, Marinozzi MC, Grünfeld JP, Noël LH, Servais A.
    Hum Pathol; 2014 Nov 07; 45(11):2326-33. PubMed ID: 25260719
    [Abstract] [Full Text] [Related]

  • 7. Dense intramembranous deposit disease: a clinical comparison of histological subtypes.
    Kashtan CE, Burke B, Burch G, Gustav Fisker S, Kim Y.
    Clin Nephrol; 1990 Jan 07; 33(1):1-6. PubMed ID: 2302866
    [Abstract] [Full Text] [Related]

  • 8. Clinico-pathologic spectrum of C3 glomerulopathy-an Indian experience.
    Viswanathan GK, Nada R, Kumar A, Ramachandran R, Rayat CS, Jha V, Sakhuja V, Joshi K.
    Diagn Pathol; 2015 Mar 17; 10():6. PubMed ID: 25889427
    [Abstract] [Full Text] [Related]

  • 9. Combined renin angiotensin blockade in childhood steroid-resistant nephrotic syndrome.
    Supavekin S, Surapaitoolkorn W, Tancharoen W, Pattaragarn A, Sumboonnanonda A.
    Pediatr Int; 2012 Dec 17; 54(6):793-7. PubMed ID: 22621380
    [Abstract] [Full Text] [Related]

  • 10. [Primary nephrotic syndrome. Follow-up of 202 pediatric patients].
    Caletti MG, Gallo G, Zumino D, Díaz MA, Vitacco M.
    Bol Med Hosp Infant Mex; 1981 Dec 17; 38(3):457-72. PubMed ID: 7271977
    [Abstract] [Full Text] [Related]

  • 11. Prognostic factors in children with membranoproliferative glomerulonephritis type I.
    García-de la Puente S, Orozco-Loza IL, Zaltzman-Girshevich S, de Leon Bojorge B.
    Pediatr Nephrol; 2008 Jun 17; 23(6):929-35. PubMed ID: 18297315
    [Abstract] [Full Text] [Related]

  • 12. Collapsing glomerulopathy in 19 patients with systemic lupus erythematosus or lupus-like disease.
    Salvatore SP, Barisoni LM, Herzenberg AM, Chander PN, Nickeleit V, Seshan SV.
    Clin J Am Soc Nephrol; 2012 Jun 17; 7(6):914-25. PubMed ID: 22461531
    [Abstract] [Full Text] [Related]

  • 13. Pattern of steroid resistant nephrotic syndrome in children living in the kingdom of Saudi Arabia: a single center study.
    Kari JA, Halawani M, Mokhtar G, Jalalah SM, Anshasi W.
    Saudi J Kidney Dis Transpl; 2009 Sep 17; 20(5):854-7. PubMed ID: 19736491
    [Abstract] [Full Text] [Related]

  • 14. Immunosuppressive treatment of the nephrotic syndrome due to mesangial lesions.
    Faedda R, Pirisi M, Satta A, Tanda F, Bartoli E.
    Clin Nephrol; 1996 Oct 17; 46(4):237-44. PubMed ID: 8905208
    [Abstract] [Full Text] [Related]

  • 15. Worsening renal failure in older chronic kidney disease patients with renal artery stenosis concurrently on renin angiotensin aldosterone system blockade: a prospective 50-month Mayo-Health-System clinic analysis.
    Onuigbo MA, Onuigbo NT.
    QJM; 2008 Jul 17; 101(7):519-27. PubMed ID: 18375475
    [Abstract] [Full Text] [Related]

  • 16. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR.
    Clin Ther; 2007 Sep 17; 29(9):1803-24. PubMed ID: 18035185
    [Abstract] [Full Text] [Related]

  • 17. Angiotensin receptor blocker reduces proteinuria independently of blood pressure in children already treated with Angiotensin-converting enzyme inhibitors.
    Seeman T, Pohl M, Misselwitz J, John U.
    Kidney Blood Press Res; 2009 Sep 17; 32(6):440-4. PubMed ID: 20016211
    [Abstract] [Full Text] [Related]

  • 18. Idiopathic membranous nephropathy and nephrotic syndrome: outcome in the era of evidence-based therapy.
    McQuarrie EP, Stirling CM, Geddes CC.
    Nephrol Dial Transplant; 2012 Jan 17; 27(1):235-42. PubMed ID: 21558430
    [Abstract] [Full Text] [Related]

  • 19. [Characteristics of pediatric C3 glomerulopathy with decreased factor H in 3 cases].
    He RJ, Xiao HJ, Wang SX, Guan N, Yao Y, Ding J.
    Zhonghua Er Ke Za Zhi; 2012 Dec 17; 50(12):939-43. PubMed ID: 23324154
    [Abstract] [Full Text] [Related]

  • 20. Low-dose dual blockade of the renin-angiotensin system improves tubular status in non-diabetic proteinuric patients.
    Renke M, Tylicki L, Rutkowski P, Wojnarowski K, Lysiak-Szydlowska W, Rutkowski B.
    Scand J Urol Nephrol; 2005 Dec 17; 39(6):511-7. PubMed ID: 16303729
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.